Browsing by Author "Srinivasan, S."

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    A Cross Sectional Study On The Prevalence Of Vitamin A Deficiency
    (Indian Society for Health and Advanced Research, 2022-08) Srinivasan, S.; S, Anu Keerthana; S, Nandhini
    Background: Vitamin A is an essential nutrient needed for normal vision, immune functions, maintenance of epithelial cell integrity, growth and development, reproductive function. It is the most important cause of preventable childhood blindness in developing countries. To estimate the prevalence of vitamin A deficiency in children ?15 yearsAim: reporting to a tertiary care centre A cross sectional study was conducted on 100 children agedMaterials & Methods: upto 15years reporting to eye OPD from April 2022- June 2022. Detailed history from mother was collected. A comprehensive ophthalmic examination including visual acuity measurement, anterior segment, fundus evaluation was done. Vitamin A deficiency was clinically assessed by using WHO classification of Xerophthalmia. TheResults: prevalence of clinical vitamin A deficiency in this study was 9%. Maximum presentation was seen in age group of >2-5 years. Prevention, early recognition by regular screening and nutritional education would decrease theConclusion: risk of developing clinical vitamin A deficiency
  • No Thumbnail Available
    Item
    Nancy Olivieri: Sometimes, truth has only one face
    (Forum for Medical Ethics Society, 2024-09) Srinivasan, S.
    Nancy Olivieri is a senior haematologist and professor at the University of Toronto, Canada. In the early 1990s, she was conducting investigator-initiated research of an experimental drug, deferiprone, in children with thalassaemia, for which a pharmaceutical company, Apotex, started giving some supplemental support. In the course of her work, Dr Olivieri found that deferiprone might not be very effective and was also possibly toxic. When she signalled her intent to disclose the risks to participants, the trials were immediately shut down and she was threatened with “all legal remedies” should she disclose her concerns. This led to 18 years of attacks from the CEO of Apotex as well as fabricated charges and harassment from the University and the Hospital for Sick Children where she worked.